Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 02, 2018 20:01 pm UTC| Business
The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3The 20ug dose of G100 shows a two-fold increase in TILs, higher than that seen at the 10ug doseConference call at 1:30 pm Pacific today SEATTLE...
Cerner Reports First Quarter 2018 Results
May 02, 2018 20:01 pm UTC| Business
KANSAS CITY, Mo., May 02, 2018 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2018 first quarter that ended March 31, 2018. Bookings in the first quarter of 2018 were $1.398 billion, an increase...
Harvard Bioscience Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
-Reports GAAP and adjusted non-GAAP revenue of $26.8 million and $27.7 million, respectively, an increase of 48% and 15%, respectively- HOLLISTON, Mass., May 02, 2018 -- Harvard Bioscience, Inc. (Nasdaq:HBIO), or the...
Trevena to Present at the Deutsche Bank 43rd Annual Healthcare Conference
May 02, 2018 20:01 pm UTC| Business
CHESTERBROOK, Pa., May 02, 2018 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Deutsche Bank 43rd Annual Healthcare Conference on Tuesday, May 8th, 2018, at 3:30 p.m. EDT in Boston,...
3D Systems Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
ROCK HILL, S.C., May 02, 2018 -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2018. For the first quarter of 2018, the company reported six percent...
Nuvectra™ Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
PLANO, Texas, May 02, 2018 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2018. Highlights Reported...
Collegium to Present at the Deutsche Bank Health Care Conference
May 02, 2018 20:01 pm UTC| Business
CANTON, Mass., May 02, 2018 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the Deutsche Bank 43rd Annual Health Care Conference on Tuesday, May 8, 2018 at 12:50 p.m. ET...